U.S. markets closed

Lannett Company, Inc. (LCI)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
6.70-0.16 (-2.33%)
At close: 4:00PM EST
Sign in to post a message.
  • T
    THT
    Again and again impairment chargers and none high impact launches
  • P
    Popeye
    Seven bucks again, just like last time going into conference call. 30% gain in three months if you bought after the last CC. We could easily have $7.5 by the end of Jan. CC is early Feb.
  • T
    THT
    From CC: "Turning to generic Advair, another potentially durable product for us. The pivotal PK trials for two 50/50 and 550 strengths had been completed by our partner Respirent. The data is currently being analyzed. Assuming the data is acceptable, we plan to submit the ANDA around the end of this calendar year or early next calendar year. Depending on the quality of our submission and the FDA review time, we believe a US launch of the product as possible next fiscal year. Based on standard assumptions, we anticipate some sales at the end of the fiscal year 2022 and substantial net sales for fiscal year 2023." So far no any news about ANDA submisssion.
  • T
    THT
    The worst decision in my life was investment in this company. No any good news, sales are down, margin shrinking accelerated, and debt payoff is approaching fast.
  • A
    A. Luis
    There don’t seem to me to be enough shares traded to make it worth the while if the shorts. What am I missing ?
  • A
    A. Luis
    Something in my gut tells me there is talk about a tender offer for LCI. It’s capitalization is a mere 290m and the company has excellent long term prospects
  • F
    Fred
    7.87 Mil Short Shares
  • b
    bipin
    company is debt free.!
  • j
    j
    Looks like something going to happen.....soon. Maybe some consolidation in the industry? Good time to buyout LCI.
    Bullish
  • P
    Popeye
    It will be just like the last time after the earnings. Down after earnings and then about 30% up gradually over the next three months. OK to buy here or better yet if it drops another 40 to 50 cents. It will be $7+ in next 2 to 3 months.
  • J
    Jack
    Morning filing hints at a merger. Perks for Crew.
  • A
    A. Luis
    The downgrade in their liquidity rating is a head fake
  • F
    Fred
    Well, back to $5. Maybe another buying opportunity. See you next quarter hopefully better.
  • j
    j
    Amazon will need a reliable supplier.
  • T
    THT
    Struggling, unloaded some shares yesterday. CC was depressing.
  • J
    Jack
    This company will be bought out.
  • A
    Anonymous
    I'm absolutely amazed that people don't see the value in LCI. Raymond James just noted -
    1) LCI's mgmt. projects adjusted EDBITDA for fiscal 2020 "significantly ahead of Street estimates".
    2) The company "plans to launch another 15-17 products by the end of fiscal 2019. These would mostly be internally developed products with equally high margins and a market value exceeding $5 billion".

    My Analysis:
    1) LCI only has 38.95M shares outstanding. If the mkt value exceeds $5B, then the value of these products will exceed $128/share (5,000M / 38.95M shares).
    2) LCI is only selling @ $5/share.

    My Conclusion:
    Assuming the article did not contain a typo for the $5B, then this stock will be a real home run for longs. I just bought more shares and will wait out all the current selling. If you compute the present value of $128/share 2 years out @ 10% growth rate, you'll come up with $105/share in today's dollars, which is 21x today's share price. The short position of 16.78M shares alone will take 9.7 days to cover based on 16.78M shares / 1.729M share avg daily volume.

    LCI today is a value stock that trades with Price/Book = 0.61 and earned $60M or $1.54/share for Q1 2019 (qtr ending 09/2018) after backing out the Goodwill and Intangible Assets that were expensed in the quarter. The company will likely become a growth stock by Yr-End 2019 that will trade @ several times book value.
    Good luck with your investing.

    Is there something I'm missing here?
  • J
    Joe
    With this stock price action, it's easy to question ones belief in Lannett's future. However, I've looked again and again at the numbers and forecasts and even with the margin erosion from loosing levo, LCI is better than a $10 stock. They have the experinece and good leadership team to get through the next two years of rough waters. Once the debt overhang is gone...it will be off to the races. The market will see this much before it happens...shorts can do as they may but if the next several quarters show good progress, the stock will soar. But, I'm investing today to reap my returns in a 5 year time frame...I will add more this week if the stock lands in the 6's. I will sell only if the price jumps more than 100% in a six month period or any new news comes out that makes me loose confidence in the leadship team. Until then, I really don't care if the shorts drive this down to 5 again...it can't stay there if our management team performs!!
  • K
    K
    About the $15.29 conversion price: LC management has been executing beautifully as reflected in the fantastic improvements in the company product line, operations, financials and stock price. I think the 15.29 conversion price besides enabling better debt terms, does something much more important - namely, bring a steady but upward direction to the stock. after jumping > 100% in 5 weeks, and then falling some - it is just too much rough and tumble which can turn of certain type of employees and even investors. If we have to keep guessing whether the next stop is + 100% or - 50%, obviously it makes the job of company management that much more difficult.

    The outstanding product line aggregations that Tim Crew & team have done within such a challenging past year should not be allowed to be submerged by tipsy up/down trading action, especially by the shorts that have been very active these years.

    the 15.29 price point provides that assurance and stability to hold and accumulate LCI , while management can focus on getting the products to market and create and execute their streagy.
    Bullish
  • A
    Anonymous
    More Good News!!!
    https://finance.yahoo.com/news/lannett-announces-expanded-agreement-strategic-115400436.html
    Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products

    •November 6, 2018

    Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products
    More
    --Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019-- PHILADELPHIA , Nov. 6, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today ...
    --Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019-- PHILADELPHIA , Nov. 6, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today ...
    --Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019-- PHILADELPHIA , Nov. 6, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today ...
    finance.yahoo.com